Clincosm LogoSign in Get a demo

crpc

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, SCLC, CRPC Trial in Tianjin (JAB-8263)

Recruiting
  • NSCLC
  • +7 more
  • Tianjin, Tianjin, China
    Tianjin
Mar 11, 2022

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Castration-resistant Prostate Cancer, CRPC Trial in Worldwide (Seviteronel: given orally once daily in 28 day cycles)

Completed
  • Castration-resistant Prostate Cancer
  • CRPC
  • Seviteronel: given orally once daily in 28 day cycles
  • Homewood, Alabama
  • +22 more
Jan 31, 2019

Castration-resistant Prostate Cancer, CRPC Trial in United States (VT-464: given orally once daily in 28 day cycles)

Completed
  • Castration-resistant Prostate Cancer
  • CRPC
  • VT-464: given orally once daily in 28 day cycles
  • Tampa, Florida
  • +4 more
Jan 31, 2019

CRPC, Prostate Cancer Trial in United States (BIND-014)

Completed
  • CRPC
  • Prostate Cancer
  • Los Angeles, California
  • +7 more
Apr 14, 2016